Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma
Zloza, Andrew, Dharmadhikari, Neal D., Huelsmann, Erica J., Broucek, Joseph R., Hughes, Tasha, Kohlhapp, Frederick J., Kaufman, Howard L.Volume:
66
Language:
english
Journal:
Cancer Immunology, Immunotherapy
DOI:
10.1007/s00262-016-1916-4
Date:
January, 2017
File:
PDF, 2.01 MB
english, 2017